A major Australian study to better understand Alzheimer's disease has started.
Australian scientists will tomorrow take delivery of the silicon they will use to redefine the kilogram.
Scientists from NASA, Europe and Australia are expected to visit the Queensland University of Technology's Carseldine campus later this year, at the completion of the southern hemisphere's only microgravity tower.
Science Industry Australia (SIA) has announced the formation of the Technology Export Manufacturing Group (TEMG) in NSW to try and boost the state and nationâ€™s reputation as an exporter of manufactured goods and services.
Agilent Technologies has announced the acquisition of the company Stratagene, effective as of today.
Siemens Medical Solutions Diagnostics, the first 'full service diagnostics' company in the world, will begin operation in Australia and New Zealand on 1 June.
The government has introduced the Global Opportunities program, promising $254.1 million over 10 years to help Australian companies become global businesses.
The Lomb Group has recently been appointed the national distributor for the Eppendorf range of products.
The Australian Institute for Commercialisation (AIC) and the Australian Nano Business Forum (ANBF) have combined to help raise industry awareness of the potential of nanotechnology.
Two respected chemists across the world from one another will share the 2007 Welch Award in Chemistry, bestowed for their achievements in theoretical chemistry.
The Australian Innovation Festival is finishing with a bang this week, with events including the AIIA iAwards and the Western Sydney Manufacturing Week 2007.
Leading international molecular biologist, Professor Nadia Rosenthal has been appointed head of Victoriaâ€™s new Regenerative Medicine Institute in an announcement made by Minister for Innovation, John Brumby.
A leading Chinese official has highlighted Australiaâ€™s opportunity to undertake new R&D collaborations with Hong Kong, in the lead-up to the 2007 Cooperative Research Centres Association Conference.
American company Sigma-Aldrich announced on 8 May that it has acquired Molecular Medicine BioServices (MMB), a biopharmaceutical contract manufacturing organisation located in Carlsbrad, California.
According to a report released by the Department of Industry Tourism and Resources which was prepared by Antonio Balaguer, Steven Playford and Ian Tranter of the Innovation Division, R&D expenditure by industry is not a stable and predictable beast.